Signe Gjedde, Lars Christian Gormsen, Anne Lene Dalkjær Riis, Jens Otto Lunde Jørgensen, Jørgen Rungby, Niels Møller, Jørgen Weeke,
and Steen Bønløkke Pedersen

Olivier Bouillanne M.D., Ph.D. a,c,*, Phasaro Hay M.D. a, Barthelemy Liabaud M.D. a,
Catherine DucheЃL M.D. b, Luc Cynober P.D., Ph.D. c,d, Christian Aussel P.D., Ph.D. b,c

Andrew Mente, PhD 1,2; Fahad Razak, BEng, Msc 1; Stefan Blankenberg, MD 3; Vlad Vuksan, PhD 4; A Darlene Davis, RN 5; Ruby Miller, RN 5; Koon Teo, MBBCh, PhD 1,2; Hertzel Gerstein, MD, Msc 1,2; Arya M. Sharma, MD, PhD 1,2; Salim Yusuf, MBBS, DPhil
1,2 ; Sonia S. Anand, MD, PhD 1,2; for the SHARE and SHARE-AP investigators

Ineke van Disa,c,d, Daan Kromhoutc, Johanna M. Geleijnsec, Jolanda M.A. Boerb
and W.M. Monique Verschurena

C. Martins, B. Kulseng, N. A. King, J. J. Holst, and J. E. Blundell

Manon G. A. van den Berg1*, Ellen L. Rasmussen-Conrad1, Koko H. Wei1,2, Heleen Lintz-Luidens3,
Johannes H. A. M. Kaanders3 and Matthias A. W. Merkx

Gary F. Mitchell, MD; Shih-Jen Hwang, PhD; Ramachandran S. Vasan, MD; Martin G. Larson, ScD; Michael J. Pencina, PhD; Naomi M. Hamburg, MD; Joseph A. Vita, MD;
Daniel Levy, MD*; Emelia J. Benjamin, MD, ScM*

To the Editor:

Steffen Desch1, Daniela Kobler1, Johanna Schmidt1, Melanie Sonnabend1, Volker Adams1,
Mahdi Sareban1, Ingo Eitel1, Matthias Bluher2, Gerhard Schuler1 and Holger Thiele1

Chronic Kidney Disease Prognosis Consortium*